Q1 2021 13F Holders as of 31 Mar 2021
-
Type / Class
-
Equity / COMMON STOCK
-
Total 13F shares
-
66,376,546
-
Share change
-
+1,933,361
-
Total reported value
-
$2,701,410,933
-
Put/Call ratio
-
100%
-
Price per share
-
$40.75
-
Number of holders
-
203
-
Value change
-
+$72,338,257
-
Number of buys
-
82
-
Number of sells
-
128
Institutional Holders of GLOBAL BLOOD THERAPEUTICS INC - COMMON STOCK (GBT) as of Q1 2021
As of 31 Mar 2021,
GLOBAL BLOOD THERAPEUTICS INC - COMMON STOCK (GBT) was held by
203 institutional
shareholders
that filed Form 13F with the SEC.
Together, they reported ownership of
66,376,546 shares.
The largest 10 holders included
BANK OF AMERICA CORP /DE/, JANUS HENDERSON GROUP PLC, VANGUARD GROUP INC, PERCEPTIVE ADVISORS LLC, BlackRock Inc., PRICE T ROWE ASSOCIATES INC /MD/, BAKER BROS. ADVISORS LP, FMR LLC, PICTET ASSET MANAGEMENT LTD, and FRANKLIN RESOURCES INC.
This page lists
203
institutional shareholders reporting positions in this security
for the Q1 2021 filing period.
| Investor |
Option |
Weight % |
Change % |
Value $ |
* Price
|
Shares |
Share Change |
Activity |
Report Period |
* Reported Price is the price of the security as of the portfolio date. This value is significant in that it is the last known price at which the security was still held.
An asterisk sign (*) next to the price indicates that the price is likely invalid.